Siemens Calls for New Therapeutic Approach

Holger Schmidt, the new president of Siemens Medical Solutions Oncology Care Division, requested today at ASTRO that the scientific and clinical oncology communities “break down the barriers of conventional thinking and explore the furthest reaches of the creative and innovative spirit”, as Siemens advocates changing the approach to treating cancer.
“By transforming the therapeutic approach, we can connect those pieces and complete the picture of truly personalized cancer care," said Schmidt.
Schmidt and John Buatti, M.D., the University of Iowa, pointed to developments in adaptive radiation therapy, including systems for volume-guided radiation therapy (VGRT) and dose-guided radiation therapy (DGRT). They also emphasized the progress in genomic and proteomic tools as examples of advances in oncology care that are redefining the therapeutic approach and creating a cohesive healthcare continuum in oncology.
“The more information you have, the better the care can be - it's as simple as that,” said Dr. Buatti. “With more information, we can be more precise in our decisions and more precise in the care we provide; however, more can be done to transform the therapeutic approach and improve the quality of care.”